360 related articles for article (PubMed ID: 24445144)
1. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
Hu Y; Mintz A; Shah SR; Quinones-Hinojosa A; Hsu W
Carcinogenesis; 2014 Jul; 35(7):1491-9. PubMed ID: 24445144
[TBL] [Abstract][Full Text] [Related]
2. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.
Shalaby AA; Presneau N; Idowu BD; Thompson L; Briggs TR; Tirabosco R; Diss TC; Flanagan AM
Mod Pathol; 2009 Aug; 22(8):996-1005. PubMed ID: 19407855
[TBL] [Abstract][Full Text] [Related]
4. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
[TBL] [Abstract][Full Text] [Related]
5. Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.
Hu Y; Feng X; Mintz A; Petty WJ; Hsu W
Oncotarget; 2016 Dec; 7(52):87124-87135. PubMed ID: 27893433
[TBL] [Abstract][Full Text] [Related]
6. Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels.
Kim JH; Hong SK; Wu PK; Richards AL; Jackson WT; Park JI
Exp Cell Res; 2014 Oct; 327(2):340-52. PubMed ID: 25128814
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factors 7 and 10 are involved in ameloblastoma proliferation via the mitogen-activated protein kinase pathway.
Nakao Y; Mitsuyasu T; Kawano S; Nakamura N; Kanda S; Nakamura S
Int J Oncol; 2013 Nov; 43(5):1377-84. PubMed ID: 24002438
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation.
Luo JC; Lin HY; Lu CL; Wang LY; Chang FY; Lin HC; Huang YC; Ng KM; Chi CW; Lee SD
Biochem Pharmacol; 2008 Oct; 76(7):841-9. PubMed ID: 18692028
[TBL] [Abstract][Full Text] [Related]
9. siRNA mediated knockdown of fibroblast growth factor receptors 1 or 3 inhibits FGF-induced anchorage-independent clonogenicity but does not affect MAPK activation.
Estes NR; Thottassery JV; Kern FG
Oncol Rep; 2006 Jun; 15(6):1407-16. PubMed ID: 16685373
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
11. Liposome-Protamine-DNA Nanoparticle-Mediated Delivery of Short Hairpin RNA Targeting Brachyury Inhibits Chordoma Cell Growth.
Hu Y; Singh R; Deng Z; Mintz A; Hsu W
J Biomed Nanotechnol; 2016 Oct; 12(10):1952-61. PubMed ID: 29360338
[TBL] [Abstract][Full Text] [Related]
12. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
13. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.
Feng L; Liao WX; Luo Q; Zhang HH; Wang W; Zheng J; Chen DB
J Cell Physiol; 2012 Jun; 227(6):2480-91. PubMed ID: 21830216
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.
Yan D; Chen D; Cool SM; van Wijnen AJ; Mikecz K; Murphy G; Im HJ
Arthritis Res Ther; 2011 Aug; 13(4):R130. PubMed ID: 21835001
[TBL] [Abstract][Full Text] [Related]
17. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.
Wakasaki T; Masuda M; Niiro H; Jabbarzadeh-Tabrizi S; Noda K; Taniyama T; Komune S; Akashi K
Neoplasia; 2010 Oct; 12(10):789-96. PubMed ID: 20927317
[TBL] [Abstract][Full Text] [Related]
18. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
[TBL] [Abstract][Full Text] [Related]
19. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.
Brown WS; Akhand SS; Wendt MK
Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137
[TBL] [Abstract][Full Text] [Related]
20. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]